CLINICAL_TRIALS
trial_result
· 2016-08-25
Clinical Trial Update: A Study to Compare Denosumab With Zoledronic Acid in Subjects With Bone Metastases From Solid Tumors [Phase 3]
Summary
A Phase 3 study comparing denosumab with zoledronic acid in patients with bone metastases has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Fractures, Bone | Phase 3 | Status: COMPLETED | Results posted: 2016-08-25